1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Bronchiectasis Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Antibiotics
  • 1.2.3 Expectorants
  • 1.2.4 Others
• 1.3 Market by Application
  • 1.3.1 Global Bronchiectasis Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Online Pharmacies
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Bronchiectasis Therapeutic Market Perspective (2016-2027)
• 2.2 Bronchiectasis Therapeutic Growth Trends by Regions
  • 2.2.1 Bronchiectasis Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Bronchiectasis Therapeutic Historic Market Share by Regions (2016-2021)
  • 2.2.3 Bronchiectasis Therapeutic Forecasted Market Size by Regions (2022-2027)
• 2.3 Bronchiectasis Therapeutic Industry Dynamic
  • 2.3.1 Bronchiectasis Therapeutic Market Trends
  • 2.3.2 Bronchiectasis Therapeutic Market Drivers
  • 2.3.3 Bronchiectasis Therapeutic Market Challenges
  • 2.3.4 Bronchiectasis Therapeutic Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Bronchiectasis Therapeutic Players by Revenue
  • 3.1.1 Global Top Bronchiectasis Therapeutic Players by Revenue (2016-2021)
  • 3.1.2 Global Bronchiectasis Therapeutic Revenue Market Share by Players (2016-2021)
• 3.2 Global Bronchiectasis Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Bronchiectasis Therapeutic Revenue
• 3.4 Global Bronchiectasis Therapeutic Market Concentration Ratio
  • 3.4.1 Global Bronchiectasis Therapeutic Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Bronchiectasis Therapeutic Revenue in 2020
• 3.5 Bronchiectasis Therapeutic Key Players Head office and Area Served
• 3.6 Key Players Bronchiectasis Therapeutic Product Solution and Service
• 3.7 Date of Enter into Bronchiectasis Therapeutic Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Bronchiectasis Therapeutic Breakdown Data by Type

• 4.1 Global Bronchiectasis Therapeutic Historic Market Size by Type (2016-2021)
• 4.2 Global Bronchiectasis Therapeutic Forecasted Market Size by Type (2022-2027)

5 Bronchiectasis Therapeutic Breakdown Data by Application

• 5.1 Global Bronchiectasis Therapeutic Historic Market Size by Application (2016-2021)
• 5.2 Global Bronchiectasis Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Bronchiectasis Therapeutic Market Size (2016-2027)
• 6.2 North America Bronchiectasis Therapeutic Market Size by Type
  • 6.2.1 North America Bronchiectasis Therapeutic Market Size by Type (2016-2021)
  • 6.2.2 North America Bronchiectasis Therapeutic Market Size by Type (2022-2027)
  • 6.2.3 North America Bronchiectasis Therapeutic Market Size by Type (2016-2027)
• 6.3 North America Bronchiectasis Therapeutic Market Size by Application
  • 6.3.1 North America Bronchiectasis Therapeutic Market Size by Application (2016-2021)
  • 6.3.2 North America Bronchiectasis Therapeutic Market Size by Application (2022-2027)
  • 6.3.3 North America Bronchiectasis Therapeutic Market Size by Application (2016-2027)
• 6.4 North America Bronchiectasis Therapeutic Market Size by Country
  • 6.4.1 North America Bronchiectasis Therapeutic Market Size by Country (2016-2021)
  • 6.4.2 North America Bronchiectasis Therapeutic Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Bronchiectasis Therapeutic Market Size (2016-2027)
• 7.2 Europe Bronchiectasis Therapeutic Market Size by Type
  • 7.2.1 Europe Bronchiectasis Therapeutic Market Size by Type (2016-2021)
  • 7.2.2 Europe Bronchiectasis Therapeutic Market Size by Type (2022-2027)
  • 7.2.3 Europe Bronchiectasis Therapeutic Market Size by Type (2016-2027)
• 7.3 Europe Bronchiectasis Therapeutic Market Size by Application
  • 7.3.1 Europe Bronchiectasis Therapeutic Market Size by Application (2016-2021)
  • 7.3.2 Europe Bronchiectasis Therapeutic Market Size by Application (2022-2027)
  • 7.3.3 Europe Bronchiectasis Therapeutic Market Size by Application (2016-2027)
• 7.4 Europe Bronchiectasis Therapeutic Market Size by Country
  • 7.4.1 Europe Bronchiectasis Therapeutic Market Size by Country (2016-2021)
  • 7.4.2 Europe Bronchiectasis Therapeutic Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Bronchiectasis Therapeutic Market Size (2016-2027)
• 8.2 Asia-Pacific Bronchiectasis Therapeutic Market Size by Type
  • 8.2.1 Asia-Pacific Bronchiectasis Therapeutic Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Bronchiectasis Therapeutic Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Bronchiectasis Therapeutic Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Bronchiectasis Therapeutic Market Size by Application
  • 8.3.1 Asia-Pacific Bronchiectasis Therapeutic Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Bronchiectasis Therapeutic Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Bronchiectasis Therapeutic Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Bronchiectasis Therapeutic Market Size by Region
  • 8.4.1 Asia-Pacific Bronchiectasis Therapeutic Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Bronchiectasis Therapeutic Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Bronchiectasis Therapeutic Market Size (2016-2027)
• 9.2 Latin America Bronchiectasis Therapeutic Market Size by Type
  • 9.2.1 Latin America Bronchiectasis Therapeutic Market Size by Type (2016-2021)
  • 9.2.2 Latin America Bronchiectasis Therapeutic Market Size by Type (2022-2027)
  • 9.2.3 Latin America Bronchiectasis Therapeutic Market Size by Type (2016-2027)
• 9.3 Latin America Bronchiectasis Therapeutic Market Size by Application
  • 9.3.1 Latin America Bronchiectasis Therapeutic Market Size by Application (2016-2021)
  • 9.3.2 Latin America Bronchiectasis Therapeutic Market Size by Application (2022-2027)
  • 9.3.3 Latin America Bronchiectasis Therapeutic Market Size by Application (2016-2027)
• 9.4 Latin America Bronchiectasis Therapeutic Market Size by Country
  • 9.4.1 Latin America Bronchiectasis Therapeutic Market Size by Country (2016-2021)
  • 9.4.2 Latin America Bronchiectasis Therapeutic Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Bronchiectasis Therapeutic Market Size (2016-2027)
• 10.2 Middle East & Africa Bronchiectasis Therapeutic Market Size by Type
  • 10.2.1 Middle East & Africa Bronchiectasis Therapeutic Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Bronchiectasis Therapeutic Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Bronchiectasis Therapeutic Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Bronchiectasis Therapeutic Market Size by Application
  • 10.3.1 Middle East & Africa Bronchiectasis Therapeutic Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Bronchiectasis Therapeutic Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Bronchiectasis Therapeutic Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Bronchiectasis Therapeutic Market Size by Country
  • 10.4.1 Middle East & Africa Bronchiectasis Therapeutic Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Bronchiectasis Therapeutic Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 GlaxoSmithKline
  • 11.1.1 GlaxoSmithKline Company Details
  • 11.1.2 GlaxoSmithKline Business Overview
  • 11.1.3 GlaxoSmithKline Bronchiectasis Therapeutic Introduction
  • 11.1.4 GlaxoSmithKline Revenue in Bronchiectasis Therapeutic Business (2016-2021)
  • 11.1.5 GlaxoSmithKline Recent Development
• 11.2 Alitair Pharmaceuticals Inc.
  • 11.2.1 Alitair Pharmaceuticals Inc. Company Details
  • 11.2.2 Alitair Pharmaceuticals Inc. Business Overview
  • 11.2.3 Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic Introduction
  • 11.2.4 Alitair Pharmaceuticals Inc. Revenue in Bronchiectasis Therapeutic Business (2016-2021)
  • 11.2.5 Alitair Pharmaceuticals Inc. Recent Development
• 11.3 Bayer AG
  • 11.3.1 Bayer AG Company Details
  • 11.3.2 Bayer AG Business Overview
  • 11.3.3 Bayer AG Bronchiectasis Therapeutic Introduction
  • 11.3.4 Bayer AG Revenue in Bronchiectasis Therapeutic Business (2016-2021)
  • 11.3.5 Bayer AG Recent Development
• 11.4 Chiesi Farmaceutici SpA
  • 11.4.1 Chiesi Farmaceutici SpA Company Details
  • 11.4.2 Chiesi Farmaceutici SpA Business Overview
  • 11.4.3 Chiesi Farmaceutici SpA Bronchiectasis Therapeutic Introduction
  • 11.4.4 Chiesi Farmaceutici SpA Revenue in Bronchiectasis Therapeutic Business (2016-2021)
  • 11.4.5 Chiesi Farmaceutici SpA Recent Development
• 11.5 Grifols SA
  • 11.5.1 Grifols SA Company Details
  • 11.5.2 Grifols SA Business Overview
  • 11.5.3 Grifols SA Bronchiectasis Therapeutic Introduction
  • 11.5.4 Grifols SA Revenue in Bronchiectasis Therapeutic Business (2016-2021)
  • 11.5.5 Grifols SA Recent Development
• 11.6 Insmed Inc
  • 11.6.1 Insmed Inc Company Details
  • 11.6.2 Insmed Inc Business Overview
  • 11.6.3 Insmed Inc Bronchiectasis Therapeutic Introduction
  • 11.6.4 Insmed Inc Revenue in Bronchiectasis Therapeutic Business (2016-2021)
  • 11.6.5 Insmed Inc Recent Development
• 11.7 Kamada Ltd
  • 11.7.1 Kamada Ltd Company Details
  • 11.7.2 Kamada Ltd Business Overview
  • 11.7.3 Kamada Ltd Bronchiectasis Therapeutic Introduction
  • 11.7.4 Kamada Ltd Revenue in Bronchiectasis Therapeutic Business (2016-2021)
  • 11.7.5 Kamada Ltd Recent Development
• 11.8 Polyphor Ltd
  • 11.8.1 Polyphor Ltd Company Details
  • 11.8.2 Polyphor Ltd Business Overview
  • 11.8.3 Polyphor Ltd Bronchiectasis Therapeutic Introduction
  • 11.8.4 Polyphor Ltd Revenue in Bronchiectasis Therapeutic Business (2016-2021)
  • 11.8.5 Polyphor Ltd Recent Development
• 11.9 Recipharm AB
  • 11.9.1 Recipharm AB Company Details
  • 11.9.2 Recipharm AB Business Overview
  • 11.9.3 Recipharm AB Bronchiectasis Therapeutic Introduction
  • 11.9.4 Recipharm AB Revenue in Bronchiectasis Therapeutic Business (2016-2021)
  • 11.9.5 Recipharm AB Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Bronchiectasis Therapeutic Scope and Market Size
Bronchiectasis Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bronchiectasis Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antibiotics
Expectorants
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Alitair Pharmaceuticals Inc.
Bayer AG
Chiesi Farmaceutici SpA
Grifols SA
Insmed Inc
Kamada Ltd
Polyphor Ltd
Recipharm AB